Sunday 18 October 2026
Export APMD’s income statement to Excel — free account
Apnimed, Inc.
APMD
Apnimed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.5 million, up 380.1% from fiscal 2024. Insiders bought in the last twelve months.
17.76
0.49
−2.68%
Follow APMD
Apnimed, Inc. (APMD) P/E ratio
As of 16 October 2026, Apnimed, Inc. (APMD) trades at a P/E ratio of 0.9×. Over the past ten years it has ranged from 0.9× (October 2026) to 1.6× (August 2026); the current reading is higher than 5% of that period.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 1.3× | 0.00% |
| FY2024 | 1.3× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 1.3× | 0.00% |
| Mar 2026 | 1.3× | 0.00% |
| Jun 2025 | 1.3× | 0.00% |
| Mar 2025 | 1.3× | — |
Against its own ten years
Low 0.9×
High 1.6×
Ten-year median
1.3×
Current reading's percentile
5
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| APMD Apnimed, Inc. | 0.9× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)